773 related articles for article (PubMed ID: 16454553)
1. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
3. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
4. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
5. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
6. Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study.
Lucas DR; Bentley G; Dan ME; Tabaczka P; Poulik JM; Mott MP
Am J Clin Pathol; 2001 Jan; 115(1):11-7. PubMed ID: 11190795
[TBL] [Abstract][Full Text] [Related]
7. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous pre-B lymphoblastic lymphoma immunohistologically mimics Ewing's sarcoma/primitive neuroectodermal tumor.
Hsiao CH; Su IJ
J Formos Med Assoc; 2003 Mar; 102(3):193-7. PubMed ID: 12783138
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
[TBL] [Abstract][Full Text] [Related]
11. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
Dunphy CH; O'Malley DP; Perkins SL; Chang CC
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):154-9. PubMed ID: 17525626
[TBL] [Abstract][Full Text] [Related]
12. Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Shad AT; Lage JM; Magrath IT; Azumi N; Harris NL; Cossman J; Jaffe ES
Am J Surg Pathol; 1998 Jul; 22(7):795-804. PubMed ID: 9669342
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.
Dworzak MN; Fritsch G; Buchinger P; Fleischer C; Printz D; Zellner A; Schöllhammer A; Steiner G; Ambros PF; Gadner H
Blood; 1994 Jan; 83(2):415-25. PubMed ID: 7506950
[TBL] [Abstract][Full Text] [Related]
14. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
Smith RG; Kitchens RL
Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
[TBL] [Abstract][Full Text] [Related]
16. The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia.
Khanlari B; Buser A; Lugli A; Tichelli A; Dirnhofer S
Leuk Lymphoma; 2003 Dec; 44(12):2055-9. PubMed ID: 14959847
[TBL] [Abstract][Full Text] [Related]
17. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
18. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
19. Non-neoplastic TdT-positive cells in bone marrow trephines with acute myeloid leukaemia before and after treatment express myeloid molecules.
Jöhrens K; Franke A; Dietel M; Anagnostopoulos I
Pathobiology; 2011; 78(1):35-40. PubMed ID: 21474974
[TBL] [Abstract][Full Text] [Related]
20. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
